228 related articles for article (PubMed ID: 19660719)
1. Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.
Chen YB; Kim HT; McDonough S; Odze RD; Yao X; Lazo-Kallanian S; Spitzer TR; Soiffer R; Antin JH; Ritz J
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1066-76. PubMed ID: 19660719
[TBL] [Abstract][Full Text] [Related]
2. A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host Disease.
Bäuerlein CA; Qureischi M; Mokhtari Z; Tabares P; Brede C; Jordán Garrote AL; Riedel SS; Chopra M; Reu S; Mottok A; Arellano-Viera E; Graf C; Kurzwart M; Schmiedgen K; Einsele H; Wölfl M; Schlegel PG; Beilhack A
Front Immunol; 2020; 11():593321. PubMed ID: 33584657
[TBL] [Abstract][Full Text] [Related]
3. Expression of α4β7 integrin on memory CD8(+) T cells at the presentation of acute intestinal GVHD.
Chen YB; McDonough S; Chen H; Kennedy J; Illiano C; Attar EC; Ballen KK; Dey BR; McAfee SL; Jagasia M; Soiffer R; Spitzer TR; Ritz J
Bone Marrow Transplant; 2013 Apr; 48(4):598-603. PubMed ID: 23042495
[TBL] [Abstract][Full Text] [Related]
4. High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation.
Lu SY; Liu KY; Liu DH; Xu LP; Huang XJ
Clin Exp Immunol; 2011 Aug; 165(2):264-77. PubMed ID: 21635226
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
[TBL] [Abstract][Full Text] [Related]
6. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M
Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336
[TBL] [Abstract][Full Text] [Related]
7. A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model.
Bäuerlein CA; Riedel SS; Baker J; Brede C; Garrote AL; Chopra M; Ritz M; Beilhack GF; Schulz S; Zeiser R; Schlegel PG; Einsele H; Negrin RS; Beilhack A
BMC Med; 2013 May; 11():134. PubMed ID: 23692886
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
Front Immunol; 2020; 11():1534. PubMed ID: 32849519
[No Abstract] [Full Text] [Related]
9. Peripheral Blood CD38 Bright CD8+ Effector Memory T Cells Predict Acute Graft-versus-Host Disease.
Khandelwal P; Lane A; Chaturvedi V; Owsley E; Davies SM; Marmer D; Filipovich AH; Jordan MB; Marsh RA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1215-22. PubMed ID: 25881755
[TBL] [Abstract][Full Text] [Related]
10. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
Front Immunol; 2021; 12():720354. PubMed ID: 34539656
[TBL] [Abstract][Full Text] [Related]
11. [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
Liu YJ; Wu DP; Li CX; He J; Qiu QC; Zhang XG
Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):835-8. PubMed ID: 17217750
[TBL] [Abstract][Full Text] [Related]
12. Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells.
Engelhardt BG; Crowe JE
Curr Top Microbiol Immunol; 2010; 341():121-46. PubMed ID: 20563712
[TBL] [Abstract][Full Text] [Related]
13. Shift of graft-versus-host-disease target organ tropism by dietary vitamin A.
Koenecke C; Prinz I; Bubke A; Schreder A; Lee CW; Pabst O; Förster R
PLoS One; 2012; 7(5):e38252. PubMed ID: 22666498
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD30 in patients with acute graft-versus-host disease.
Chen YB; McDonough S; Hasserjian R; Chen H; Coughlin E; Illiano C; Park IS; Jagasia M; Spitzer TR; Cutler CS; Soiffer RJ; Ritz J
Blood; 2012 Jul; 120(3):691-6. PubMed ID: 22661699
[TBL] [Abstract][Full Text] [Related]
15. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease
Han L; Jin H; Zhou L; Zhang X; Fan Z; Dai M; Lin Q; Huang F; Xuan L; Zhang H; Liu Q
Front Immunol; 2018; 9():669. PubMed ID: 29740427
[TBL] [Abstract][Full Text] [Related]
16. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
[TBL] [Abstract][Full Text] [Related]
17. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
18. The Ex Vivo Treatment of Donor T Cells with Cosalane, an HIV Therapeutic and Small-Molecule Antagonist of CC-Chemokine Receptor 7, Separates Acute Graft-versus-Host Disease from Graft-versus-Leukemia Responses in Murine Hematopoietic Stem Cell Transplantation Models.
Fowler KA; Li K; Whitehurst CB; Bruce DW; Moorman NJ; Aubé J; Coghill JM
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1062-1074. PubMed ID: 30668984
[TBL] [Abstract][Full Text] [Related]
19. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
[TBL] [Abstract][Full Text] [Related]
20. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation.
Clave E; Busson M; Douay C; Peffault de Latour R; Berrou J; Rabian C; Carmagnat M; Rocha V; Charron D; Socié G; Toubert A
Blood; 2009 Jun; 113(25):6477-84. PubMed ID: 19258596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
